BI Logo 385 12.5/2.5 Pill - red oval, 19mm

Generic Name: empagliflozin/linagliptin/metformin

Pill with imprint BI Logo 385 12.5/2.5 is Red, Oval and has been identified as Trijardy XR empagliflozin 12.5 mg / linagliptin 2.5 mg / metformin hydrochloride 1000 mg extended-release. It is supplied by Boehringer Ingelheim and Eli Lilly and Company.

Trijardy XR is used in the treatment of Type 2 Diabetes and belongs to the drug class antidiabetic combinations. Trijardy XR empagliflozin 12.5 mg / linagliptin 2.5 mg / metformin hydrochloride 1000 mg extended-release is not a controlled substance under the Controlled Substances Act (CSA).

Images for BI Logo 385 12.5/2.5

Trijardy XR

Generic Name

empagliflozin/linagliptin/metformin

Imprint

BI Logo 385 12.5/2.5

Strength

empagliflozin 12.5 mg / linagliptin 2.5 mg / metformin hydrochloride 1000 mg extended-release

Color

Red

Size

19.00 mm

Shape

Oval

Availability

Prescription only

Drug Class

Antidiabetic combinations

CSA Schedule

Not a controlled drug

Labeler / Supplier

Boehringer Ingelheim and Eli Lilly and Company

National Drug Code (NDC)

00597-0385

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer